Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives

IRVINE, Calif. & PHILADELPHIA–(BUSINESS WIRE)–Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and Temple Health, Philadelphia’s 979-bed academic health system, announced today that they are entering into a strategic innovation collaboration. With an emphasis on advancing the forefront remote patient monitoring and telehealth, as well as automating high-quality care, the … [Read more…]

Sunovion Answers Is Named a J.D. Power 2022 Certified Customer Service Program℠

– Sunovion’s patient support program is recognized four years in a row by J.D. Power for providing an outstanding customer service experience – MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the Company’s patient support program, Sunovion Answers, has been named as a J.D. Power 2022 Certified Customer Service Program℠. Sunovion Answers has been … [Read more…]

Arcturus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 28, 2023

Arcturus to present at the Guggenheim Healthcare Talks: Genomic Medicines & Rare Disease Day, April 3, 2023 SAN DIEGO–(BUSINESS WIRE)–Arcturus Therapeutics Holdings Inc. (the “Company,” “Arcturus,” Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced … [Read more…]

The American Society of Transplant Surgeons Position Statement Supports Use of CareDx’s AlloSure Kidney for Organ Transplant Surveillance

Statement Also Supports Use of AlloSure Heart and AlloMap Heart   BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the issuance of a new position statement by the American Society of … [Read more…]

Flagship Pioneering Unveils Ampersand Biomedicines to Create Highly Effective Medicines That Are Programed to Act Only Where Needed

The Company’s Proprietary Address, Navigate, Design (AND)™ Platform Produces Medicines that are Better, Safer and More Tolerable for Patients After Two Years of Development, Flagship Commits $50 Million to Advance the Company’s Platform and Build an Initial Pipeline of Therapeutics CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biotech–Flagship Pioneering, the bioplatform innovation company, today unveiled Ampersand Biomedicines, a company creating … [Read more…]

InformedDNA Provides Access to Genomically Guided Healthcare

Increased focus on product development aims to support health plans to better integrate genomics into member benefits ST. PETERSBURG, Fla.–(BUSINESS WIRE)–InformedDNA®, the nation’s leading applied genomics solutions company, today announced it is building on their foundation in genomics care delivery and benefits management expertise to launch a new set of scalable solutions to enable wider … [Read more…]

Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform

— Partnership will further validate Exscientia’s functional drug testing platform to predict response in haematological cancers — OXFORD, England & BERLIN, Germany–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today announced a new collaboration with Charité – Universitätsmedizin Berlin (Charité) to utilise Exscientia’s AI-driven precision medicine platform in haematological cancers. Under the collaboration, Charité will evaluate the potential … [Read more…]

Seres Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

– SER-109 Biologics License Application (BLA) under review with U.S. Food and Drug Administration (FDA) with target action date of April 26, 2023 under Prescription Drug User Fee Act (PDUFA) – – Anticipate SER-109 commercial launch soon after potential FDA approval decision – – SER-155 Phase 1b study cohort 2 enrollment ongoing; anticipate reporting initial … [Read more…]

Vizient Hosts Congressional Briefing on Pressures Facing Hospitals

IRVING, Texas–(BUSINESS WIRE)–Yesterday on Capitol Hill, Vizient, Inc. hosted a policy briefing titled, “Provider Pressures Persist: Hospitals’ Struggles Against Financial, Workforce and Supply Chain Strains” at the Rayburn House Office Building in Washington, D.C. Attended by more than 50 Congressional staff and other healthcare stakeholders, this briefing focused on how hospitals are responding to mounting … [Read more…]

Nomad Health Appoints Former Bank of America Executive Anne Walker as New CFO

Company expands leadership team to further accelerate market growth NEW YORK–(BUSINESS WIRE)–Nomad Health, the leading digital marketplace for temporary healthcare jobs, announced that Anne Walker has joined the company as its new chief financial officer (CFO). Responsible for managing Nomad Health’s financial strategy as it continues modernizing the healthcare staffing industry, Walker has over 20 … [Read more…]